The Clinical Development Team at Cerebral Therapeutics is responsible for designing, implementing, and overseeing clinical trials that evaluate the safety and efficacy of innovative therapies for refractory epilepsy. This multidisciplinary team collaborates closely with regulatory bodies, manages project timelines, and ensures compliance with quality standards to advance drug candidates through the clinical pipeline, ultimately aiming to bring transformative treatments to patients in need.